Aspirin monotherapy vs. dual antiplatelet therapy in diabetic patients following coronary artery bypass graft (CABG)

Where do we stand?

Salem Salem, Sameh Askandar, Rami Khouzam

Research output: Contribution to journalEditorial

2 Citations (Scopus)
Original languageEnglish (US)
Article number213
JournalAnnals of Translational Medicine
Volume5
Issue number10
DOIs
StatePublished - Jan 1 2017

Fingerprint

Coronary Artery Bypass
Aspirin
Transplants
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Aspirin monotherapy vs. dual antiplatelet therapy in diabetic patients following coronary artery bypass graft (CABG) : Where do we stand? / Salem, Salem; Askandar, Sameh; Khouzam, Rami.

In: Annals of Translational Medicine, Vol. 5, No. 10, 213, 01.01.2017.

Research output: Contribution to journalEditorial

@article{7b36de5fbad64ab390085b00fa0e352e,
title = "Aspirin monotherapy vs. dual antiplatelet therapy in diabetic patients following coronary artery bypass graft (CABG): Where do we stand?",
author = "Salem Salem and Sameh Askandar and Rami Khouzam",
year = "2017",
month = "1",
day = "1",
doi = "10.21037/atm.2017.03.98",
language = "English (US)",
volume = "5",
journal = "Annals of Translational Medicine",
issn = "2305-5839",
publisher = "AME Publishing Company",
number = "10",

}

TY - JOUR

T1 - Aspirin monotherapy vs. dual antiplatelet therapy in diabetic patients following coronary artery bypass graft (CABG)

T2 - Where do we stand?

AU - Salem, Salem

AU - Askandar, Sameh

AU - Khouzam, Rami

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85019890052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019890052&partnerID=8YFLogxK

U2 - 10.21037/atm.2017.03.98

DO - 10.21037/atm.2017.03.98

M3 - Editorial

VL - 5

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

SN - 2305-5839

IS - 10

M1 - 213

ER -